Literature DB >> 6472595

Acute operation and preventive nimodipine improve outcome in patients with ruptured cerebral aneurysms.

L M Auer.   

Abstract

Sixty-five patients with ruptured aneurysms were operated upon within 48 to 72 hours after subarachnoid hemorrhage (SAH) and were treated with a regimen of intra- and postoperative nimodipine for the prevention of symptomatic vasospasm. The clinical grading (Hunt and Hess) was I to III in 49 patients and IV or V in 16. The SAH was mild in 15 patients, moderate in 27, and severe in 23; 12 patients harbored an intracerebral hematoma, and 6 had intraventricular bleeding. Acute hydrocephalus was observed on preoperative computed tomography (CT) in 19 patients. On CT 3 days postoperatively (i.e., Day 3-4 after SAH), 30 of 65 patients still had subarachnoid blood; however, severe symptomatic vasospasm as the deciding threatening event during the delayed postoperative period was not encountered in this series. Transient symptoms of ischemia were noted in 2 patients (3%) and were accompanied by angiographic spasm in 1. Irreversible neurological deficit occurred in 2 patients (3%); in 1 of these, it was a complication of postoperative control angiography. Of the patients preoperatively graded I or II, 96% had an excellent to fair outcome 6 months postoperatively, and 1 patient (4%) had died because of a surgical complication. Among patients preoperatively graded III or IV, 86% had an excellent to fair outcome, and the remaining 14% had a poor outcome. Shunt-dependent hydrocephalus developed in 7% of the patients. Acute surgical repair of ruptured cerebral aneurysms and preventive topical and intravenous administration of nimodipine reduce management complications and improve outcome; above all, ischemic lesions from symptomatic vasospasm are reduced to a minimum.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6472595     DOI: 10.1227/00006123-198407000-00011

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  44 in total

1.  Treatment of subarachnoid hemorrhage with human albumin: ALISAH study. Rationale and design.

Authors:  Jose I Suarez; Renee H Martin
Journal:  Neurocrit Care       Date:  2010-10       Impact factor: 3.210

2.  The safety and feasibility of continuous intravenous magnesium sulfate for prevention of cerebral vasospasm in aneurysmal subarachnoid hemorrhage.

Authors:  Abutaher M Yahia; Jawad F Kirmani; Adnan I Qureshi; Lee R Guterman; L Nelson Hopkins
Journal:  Neurocrit Care       Date:  2005       Impact factor: 3.210

3.  Changes in the levels of neuropeptide Y-LI in the external jugular vein in connection with vasoconstriction following subarachnoid haemorrhage in man. Involvement of sympathetic neuropeptide Y in cerebral vasospasm.

Authors:  R Juul; L Edvinsson; T A Fredriksen; R Ekman; A O Brubakk; S E Gisvold
Journal:  Acta Neurochir (Wien)       Date:  1990       Impact factor: 2.216

Review 4.  Aneurysmal subarachnoid hemorrhage: prevention of delayed ischemic dysfunction with intravenous nimodipine.

Authors:  B Ljunggren; L Brandt; H Säveland; B Romner; T Ryman; K E Andersson
Journal:  Neurosurg Rev       Date:  1987       Impact factor: 3.042

5.  Prevention of vasospasm in subarachnoid haemorrhage. A controlled study with nimodipine.

Authors:  J Philippon; R Grob; F Dagreou; M Guggiari; M Rivierez; P Viars
Journal:  Acta Neurochir (Wien)       Date:  1986       Impact factor: 2.216

Review 6.  Nimodipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in cerebrovascular disease.

Authors:  M S Langley; E M Sorkin
Journal:  Drugs       Date:  1989-05       Impact factor: 9.546

7.  Experimental intracerebral haemorrhage: the effect of nimodipine pretreatment.

Authors:  E J Sinar; A D Mendelow; D I Graham; G M Teasdale
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-05       Impact factor: 10.154

8.  Management morbidity and mortality in grade IV and V patients with aneurysmal subarachnoid haemorrhage.

Authors:  V Seifert; H A Trost; D Stolke
Journal:  Acta Neurochir (Wien)       Date:  1990       Impact factor: 2.216

9.  Acute surgery in intracranial aneurysms. Experience with 100 cases.

Authors:  J Bidziński; A Marchel; M Pastuszko
Journal:  Acta Neurochir (Wien)       Date:  1990       Impact factor: 2.216

10.  Pharmacokinetics of nimodipine in patients with aneurysmal subarachnoid haemorrhage.

Authors:  E Vinge; K E Andersson; L Brandt; B Ljunggren; L G Nilsson; S Rosendal-Helgesen
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.